168 related articles for article (PubMed ID: 36606606)
1. The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients.
Suzuki R; Horage-Okutsu Y; Kawahara T; Nakamura K; Shiraishi E; Iwahata H; Suzuki-Takahashi Y; Sugishita Y; Takae S; Suzuki N
J Obstet Gynaecol Res; 2023 Mar; 49(3):973-979. PubMed ID: 36606606
[TBL] [Abstract][Full Text] [Related]
2. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
3. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
Cakmak H; Katz A; Cedars MI; Rosen MP
Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation.
İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M
Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878
[TBL] [Abstract][Full Text] [Related]
5. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series.
Russo M; Liu K; Chan C
Reprod Biol Endocrinol; 2020 Jun; 18(1):59. PubMed ID: 32503566
[TBL] [Abstract][Full Text] [Related]
7. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre.
Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E
J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483
[TBL] [Abstract][Full Text] [Related]
8. Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients.
Campos APC; Geber GP; Hurtado R; Sampaio M; Geber S
JBRA Assist Reprod; 2018 Nov; 22(4):352-354. PubMed ID: 30264947
[TBL] [Abstract][Full Text] [Related]
9. Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre.
Simi G; Obino ME; Casarosa E; Litta P; Artini PG; Cela V
Gynecol Endocrinol; 2015; 31(12):966-70. PubMed ID: 26370262
[TBL] [Abstract][Full Text] [Related]
10. Random-start ovarian stimulation in patients with cancer.
Cakmak H; Rosen MP
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
[TBL] [Abstract][Full Text] [Related]
11. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
12. Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts.
Alexander VM; Martin CE; Schelble AP; Laufer AB; Hardi A; McKenzie LJ; Hipp HS; Kawwass JF; Spencer JB; Jungheim ES
J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102080. PubMed ID: 33545413
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of random-start controlled ovarian stimulation in cancer patients.
Kim JH; Kim SK; Lee HJ; Lee JR; Jee BC; Suh CS; Kim SH
J Korean Med Sci; 2015 Mar; 30(3):290-5. PubMed ID: 25729252
[TBL] [Abstract][Full Text] [Related]
14. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
15. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.
Cavagna F; Pontes A; Cavagna M; Dzik A; Donadio NF; Portela R; Nagai MT; Gebrim LH
Curr Oncol; 2018 Dec; 25(6):e527-e532. PubMed ID: 30607119
[TBL] [Abstract][Full Text] [Related]
16. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
[TBL] [Abstract][Full Text] [Related]
17. Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report.
Cai H; Shen H
Braz J Med Biol Res; 2016; 49(6):e5227. PubMed ID: 27191608
[TBL] [Abstract][Full Text] [Related]
18. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
[TBL] [Abstract][Full Text] [Related]
19. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
20. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
Creux H; Monnier P; Son WY; Tulandi T; Buckett W
Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
